J.D. Mowery serves as the Division President for Bora Pharmaceuticals' CDMO business, driving strategic direction and operational excellence across global contract development and manufacturing services. With extensive experience in the biopharmaceutical industry, J.D. has held several key positions, including President and CEO at KBI Biopharma, COO of Treadwell Therapeutics, and leadership roles at AGC Biologics and Juno Therapeutics, where responsibilities included overseeing GMP operations and managing complex drug development challenges. J.D. also contributes as a Board Member at AST, focuses on aseptic manufacturing innovations, and holds degrees in Project Management and Business Administration.